Carregant...
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
BACKGROUND: TP53 mutation is the most common mutation in hepatocellular carcinoma (HCC), and it affects the progression and prognosis of HCC. We investigated how TP53 mutation regulates the HCC immunophenotype and thus affects the prognosis of HCC. METHODS: We investigated TP53 mutation status and R...
Guardat en:
| Publicat a: | EBioMedicine |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491941/ https://ncbi.nlm.nih.gov/pubmed/30885723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.03.022 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|